{
}
Pharmaceutical companies are increasingly focusing on access to medicines in low-income countries, with Novartis leading the way by integrating access plans into 96% of its late-stage drug projects. However, many companies still prioritize the US market, resulting in limited availability of essential medicines globally. Roche aims to double patient treatment numbers in low-income regions by 2026, yet significant gaps in transparency and patient reach persist across the industry.
Jayasree Iyer
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pharmaceutical industry struggles to improve access to medicine in low-income countries
Bristol-Myers Squibb Company
GSK plc
Hoffmann-La Roche AG
AbbVie Inc.
Sanofi
Novo Nordisk A/S
Novartis AG
Johnson & Johnson
Pfizer Inc.
GBR
CHE
NLD
Jayasree Iyer
Sabastine Wakdok
Show more
14:30 19.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Emerging Startups
Cryptocurrency Trends
Funding Rounds & Investments
Fintech Startups
Venture Capital Investments
AI Innovations
Retail and Consumer Goods
Global Trade Developments
Private Equity Deals
Economic Indicators
Crypto Adoption and Integration
Government Economic Policies
Market Analysis and Predictions
Crypto Policies and Governance
Product Launches
IPOs & SPACs
Macro-economic Trends
Countries:
Companies:
Nvidia Corporation
NVIDIA Corporation
Microsoft Corporation
Apple Inc.
SWIGGY LIMITED
Vecmocon Technologies Ltd.
Amazon.com Inc.
Medius Holdings Co., Ltd.
SITC International Holdings Company Limited
Firefly AB (publ)
Aeon Bank (M) Berhad Bhd
AF DOBRA, SICAV, S.A.
Alibaba Group Holding Limited
Getty Images Holdings, Inc.
Sunnova Energy International Inc.
QUALCOMM Incorporated
Alphawave IP Group plc
Grab2Go AS
HDB Financial Services Ltd.
Zhejiang Leapmotor Technology Co., Ltd.
Currencies:
People: